The International Livestock Research Institute (ILRI) is a leading global non-profit research organization focused on improving food security and reducing poverty through livestock science. As a member of the CGIAR global research partnership, ILRI works at the intersection of animal health, human health, and environmental sustainability, particularly in low- and middle-income countries across Africa and Asia. The institute is co-hosted by the governments of Kenya and Ethiopia and maintains a network of regional offices.
ILRI’s research priorities include the control of zoonotic diseases, antimicrobial resistance (AMR), food safety, animal genetics, and sustainable livestock productivity. It is notably active in 'One Health' initiatives, integrating veterinary and human health research to prevent pandemics like Rift Valley Fever and MERS. The organization bridges the gap between laboratory discovery and field application, partnering with private pharmaceutical companies, governments, and international agencies to develop and deploy veterinary vaccines and diagnostics.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Veterinary Research & Zoonotic Therapeutics
SIZE & FINANCIALS
Employees:501-1000
Revenue:$50M-$100M
Founded:1994
Ownership:nonprofit
Status:operating
FUNDING
Stage:Not Applicable
Total Raised:$95.4M
Investors:CGIAR Trust Fund, Bill & Melinda Gates Foundation, USAID, European Union, UK Department for International Development (DFID), German Federal Ministry for Economic Cooperation and Development (BMZ)
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 2 (Human), Commercial (Veterinary)
Modalities:Live-attenuated vaccines, Recombinant vaccines, Viral vectors (ChAdOx1), Diagnostics, Genomics
Active Trials:4
Trial Phases:Phase 1: 1 | Phase 2: 1 | Phase 4: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:CGIAR System Organization
Subsidiaries:Biosciences eastern and central Africa (BecA-ILRI Hub), Kapiti Plains Estate Ltd
Key Partnerships:HIPRA (ASF vaccine development consortium), GALVmed (Commercialization and delivery of livestock vaccines), University of Oxford (ChAdOx1 platform for RVF and MERS), Zoetis (One Health and livestock health initiatives), Illumina (Genomic preparedness and surveillance), KEMRI-Wellcome Trust (Human clinical trials)
COMPETITION
Position:Leader
Competitors:Pirbright Institute, The Roslin Institute, GALVmed (Partner/Competitor in distribution), Boehringer Ingelheim Animal Health, Zoetis (Partner/Competitor)
LEADERSHIP
Key Executives:
Appolinaire Djikeng - Director General
Martyn Jeggo - Board Chair
Siboniso Moyo - Deputy Director General - Research, Partnerships and Impact
Scientific Founders:Peter Doherty (Patron and Nobel Laureate)
Board Members:Andrew Peters, Jonathan Mueke, Regassa Fikru, Jessica Fanzo, Patrick Caron, Li Lin Foo
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with International Livestock Research Institute (ILRI). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.